Printer Friendly

Caisson, CordenPharma in Mfg. pact.

Caisson Biotech, a provider of half-life extension and drug delivery, has established a global manufacturing partnership with CordenPharma, a full-service contract development and manufacturing organization (CDMO) manufacturing APIs and drug products through a network of cGMP facilities across Europe and the U.S.

Caisson has demonstrated successful technology transfer and cGMP scale-up with its pharmaceutical partners using its heparosan-based half-life extension and drug delivery platform, HEPtune, and will establish similar capabilities with CordenPharma in order to supply licensing partners with HEPtune drug conjugate material. As a manufacturer of the HEPtune technology, CordenPharma will provide process development and manufacture of complex carbohydrates, including carbohydrate-based polymers and glyco-conjugates, which are an integral component of its peptides, lipids and carbohydrates technology platform offering.

"We are excited to announce a manufacturing relationship with CordenPharma," said Breca Tracy, vice president and managing director, Caisson. "CordenPharma's experience manufacturing carbohydrates and polyethylene glycol drug conjugates makes CordenPharma an ideal scale-up manufacturing partner and will accelerate our capabilities to fulfill requests for larger quantities of quality material for preclinical and clinical studies."

Mimoun Ayoub, director, global peptides, lipids, carbohydrates and injectables platforms, CordenPharma, said, "We are delighted that Caisson Biotech has selected CordenPharma to serve as a manufacturer and supplier of HEPtune-related materials. This potentially disruptive technology is a natural fit for CordenPharma's peptides, lipids and carbohydrates platform, and we look forward to supporting Caisson's partners as they develop and commercialize life-saving therapeutics."

COPYRIGHT 2016 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:INDUSTRY NEWS
Publication:Contract Pharma
Date:May 1, 2016
Previous Article:BMS to acquire Padlock.
Next Article:Cryoport to support ImmunoCellular's cold chain logistics.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters